
Dissecting strategies to tune the therapeutic potential of SARS-CoV-2–specific monoclonal antibody CR3022
Author(s) -
C. Atyeo,
M.D. Slein,
S. Fischinger,
J. Burke,
A. Schäfer,
S.R. Leist,
N.A. Kuzmina,
C. Mire,
A. Honko,
R. Johnson,
N. Storm,
M. Bernett,
P. Tong,
T. Zuo,
J. Lin,
A. Zuiani,
C. Linde,
T. Suscovich,
D.R. Wesemann,
A. Griffiths,
J.R. Desjarlais,
B.D. Juelg,
J. Goudsmit,
A. Bukreyev,
R. Baric,
G. Alter
Publication year - 2021
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/eefc-r954
Subject(s) - monoclonal antibody , virology , covid-19 , antibody , biology , medicine , immunology , pathology , infectious disease (medical specialty) , outbreak , disease